Literature DB >> 12357094

Relationship between tobacco smoking and positive and negative symptoms in schizophrenia.

Ashwin A Patkar1, Raman Gopalakrishnan, Allan Lundy, Frank T Leone, Kenneth M Certa, Stephen P Weinstein.   

Abstract

In an attempt to understand the reasons behind the high prevalence of tobacco smoking in patients with schizophrenia, the study examined whether specific symptoms of schizophrenia were associated with smoking. Standardized assessments of nicotine dependence (Fagerstrom Test for Nicotine Dependence) and psychopathology (Positive and Negative Syndrome Scale) were performed on 87 inpatients with schizophrenia. Nearly 76% of patients were nicotine dependent. Significant positive correlations were found between Fagerstrom scores and the total negative symptom score and scores on the negative symptom subscales of blunted affect, social withdrawal, difficulty in abstract thinking, and stereotyped thinking. Fagerstrom scores were also significantly associated with impairment in attention, orientation, thinking, and impulse control. Positive symptoms were not significantly associated with smoking. A combination of negative symptoms, duration of illness, and alcohol use optimally predicted smoking in the sample. Neurobiological mechanisms could possibly underlie some of our findings and require further investigation.

Entities:  

Mesh:

Year:  2002        PMID: 12357094     DOI: 10.1097/00005053-200209000-00005

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  34 in total

1.  Ten critical reasons for treating tobacco dependence in inpatient psychiatry.

Authors:  Judith J Prochaska
Journal:  J Am Psychiatr Nurses Assoc       Date:  2009-12       Impact factor: 2.385

2.  A smoking ban in psychiatric units: threat or opportunity?

Authors:  Lindsay Banham; Simon Gilbody; Helen Lester
Journal:  Ment Health Fam Med       Date:  2008-09

3.  Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction?

Authors:  Judith J Prochaska
Journal:  Drug Alcohol Depend       Date:  2010-04-07       Impact factor: 4.492

4.  Predictors of smoking cessation group treatment engagement among veterans with serious mental illness.

Authors:  Letitia E Travaglini; Lan Li; Clayton H Brown; Melanie E Bennett
Journal:  Addict Behav       Date:  2017-07-10       Impact factor: 3.913

5.  Genetics and smoking.

Authors:  Anu Loukola; Jenni Hällfors; Tellervo Korhonen; Jaakko Kaprio
Journal:  Curr Addict Rep       Date:  2014-03-01

6.  Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.

Authors:  Roman Kotov; Lin T Guey; Evelyn J Bromet; Joseph E Schwartz
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

Review 7.  [Why do schizophrenic patients smoke?].

Authors:  K Cattapan-Ludewig; S Ludewig; E Jaquenoud Sirot; M Etzensberger; F Hasler
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

8.  In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.

Authors:  Irina Esterlis; Mohini Ranganathan; Frederic Bois; Brian Pittman; Marina R Picciotto; Lara Shearer; Alan Anticevic; Jon Carlson; Mark J Niciu; Kelly P Cosgrove; D Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2013-11-13       Impact factor: 13.382

Review 9.  Psychotic symptoms in patients with medical disorders.

Authors:  Ashwin A Patkar; Rajnish Mago; Prakash S Masand
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

10.  Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls.

Authors:  Michelle L Esterberg; Erin M Jones; Michael T Compton; Elaine F Walker
Journal:  Schizophr Res       Date:  2007-09-25       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.